AAA stent graft hits U.S. market

Editorial Staff | | Cardiovascular Business | Vascular & Endovascular

The FDA has approved Lombard Medical Technologies' Aorfix, a stent graft for the endovascular repair of abdominal aortic aneurysms (AAAs), for commercial sale in the U.S.

The agency based its decision on data from the U.S. PYTHAGORAS prospective, controlled trial, which included both standard and difficult-to-treat cases of AAAs. The U.S. approval for Aorfix includes a label indication for the treatment of patients with angulations at the neck of the aneurysm from 0 to 90 degrees, according to the London-based company. In Europe, Aorfix is already licensed to treat neck angulations of
up to 90 degrees.

The PYTHAGORAS trial included 218 patients at risk of aneurysm rupture; 151 patients with neck angles greater than 60 degrees and 67 patients with neck angles less than 60 degrees.
 

Editorial Staff

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."